Related Experiment Videos
Pyrroline-5-carboxylate in human plasma.
Metabolism: Clinical and Experimental
|August 1, 1984
Summary
A new assay allows measurement of pyrroline-5-carboxylate in biological fluids. This advance reveals elevated levels in type II hyperprolinemia, aiding study of its regulatory roles.
Area of Science:
- Biochemistry
- Metabolic pathways
- Enzyme kinetics
Background:
- Pyrroline-5-carboxylate (P5C) is a key intermediate in amino acid metabolism, linking proline, ornithine, and glutamate.
- Emerging evidence suggests P5C possesses regulatory functions across various human tissues.
- Previous physiological studies were hampered by the lack of a sensitive assay for P5C.
Purpose of the Study:
- To develop and validate a highly sensitive assay for quantifying pyrroline-5-carboxylate in biological samples.
- To establish normal physiological levels of P5C in human plasma, urine, and saliva.
- To investigate P5C levels in patients with type II hyperprolinemia.
Main Methods:
- Utilized purified Escherichia coli pyrroline-5-carboxylate reductase to create a novel, ultrasensitive assay.
- Applied the new assay to measure P5C concentrations in human plasma, urine, and saliva.
- Quantified P5C levels in two patients diagnosed with type II hyperprolinemia.
Main Results:
- The developed assay demonstrates sensitivity 100- to 1000-fold greater than existing methods.
- Physiological concentrations of P5C were successfully quantified in normal human plasma, urine, and saliva.
- Patients with type II hyperprolinemia exhibited P5C plasma levels 10- to 20-fold higher than normal.
Conclusions:
- A robust and sensitive assay for pyrroline-5-carboxylate is now available for use in all biological fluids.
- The assay facilitates the measurement of P5C in conditions like type II hyperprolinemia, previously undetectable.
- This breakthrough enables further research into the regulatory functions of pyrroline-5-carboxylate in human physiology and disease.